PubMed:26646445
Annnotations
Glycan-Motif
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 632-639 | https://glytoucan.org/Structures/Glycans/G00051MO | denotes | Lewis X |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 632-639 | Glycan_Motif | denotes | Lewis X | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G01187XC|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00051MO |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 632-639 | http://www.glycoepitope.jp/epitopes/EP0011 | denotes | Lewis X |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 632-639 | https://glytoucan.org/Structures/Glycans/G00051MO | denotes | Lewis X |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-98 | Sentence | denotes | Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer. |
| TextSentencer_T2 | 99-167 | Sentence | denotes | Aberrant glycosylation is highly associated with cancer progression. |
| TextSentencer_T3 | 168-409 | Sentence | denotes | The aim of this study was to compare bifucosylated N-glycans in sera obtained from healthy controls and breast cancer patients, with the goal of identifying a potential indicator for monitoring the recurrence and metastasis of breast cancer. |
| TextSentencer_T4 | 410-549 | Sentence | denotes | A unique structural pattern of bifucosylated N-glycan, with both core and antennary fucosylation, was identified in breast cancer patients. |
| TextSentencer_T5 | 550-689 | Sentence | denotes | The spectrum of antennary fucosylation was a composite of the standard spectra of Lewis X and H2, indicating a mixture of the two epitopes. |
| TextSentencer_T6 | 690-999 | Sentence | denotes | Permethylated N-glycans of the glycoproteins extracted from 91 breast cancer patients and 43 healthy controls were detected using linear ion-trap quadrupole-electrospray ionization mass spectrometry, which appeared to be a highly sensitive and useful approach in the detection and identification of N-glycans. |
| TextSentencer_T7 | 1000-1185 | Sentence | denotes | To evaluate MS profile data, several statistical tools were applied, including Student's t-test, partial least squares discriminant analysis and receiver-operating characteristic curve. |
| TextSentencer_T8 | 1186-1337 | Sentence | denotes | The results showed that the measurement of bifucosylation degree and CEA levels had an improved diagnostic performance compared with that of CEA alone. |
| TextSentencer_T9 | 1338-1501 | Sentence | denotes | We compared the potential of bifucosylated N-glycan as an indicator of breast cancer recurrence with the current clinical biomarkers, i.e., CEA, CA 15-3 and CA125. |
| TextSentencer_T10 | 1502-1668 | Sentence | denotes | The result revealed that, compared with CEA, CA 15-3 and CA125, the bifucosylation degree of N-glycans could be a more reliable indicator of breast cancer recurrence. |
| T1 | 0-98 | Sentence | denotes | Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer. |
| T2 | 99-167 | Sentence | denotes | Aberrant glycosylation is highly associated with cancer progression. |
| T3 | 168-409 | Sentence | denotes | The aim of this study was to compare bifucosylated N-glycans in sera obtained from healthy controls and breast cancer patients, with the goal of identifying a potential indicator for monitoring the recurrence and metastasis of breast cancer. |
| T4 | 410-549 | Sentence | denotes | A unique structural pattern of bifucosylated N-glycan, with both core and antennary fucosylation, was identified in breast cancer patients. |
| T5 | 550-689 | Sentence | denotes | The spectrum of antennary fucosylation was a composite of the standard spectra of Lewis X and H2, indicating a mixture of the two epitopes. |
| T6 | 690-999 | Sentence | denotes | Permethylated N-glycans of the glycoproteins extracted from 91 breast cancer patients and 43 healthy controls were detected using linear ion-trap quadrupole-electrospray ionization mass spectrometry, which appeared to be a highly sensitive and useful approach in the detection and identification of N-glycans. |
| T7 | 1000-1185 | Sentence | denotes | To evaluate MS profile data, several statistical tools were applied, including Student's t-test, partial least squares discriminant analysis and receiver-operating characteristic curve. |
| T8 | 1186-1337 | Sentence | denotes | The results showed that the measurement of bifucosylation degree and CEA levels had an improved diagnostic performance compared with that of CEA alone. |
| T9 | 1338-1501 | Sentence | denotes | We compared the potential of bifucosylated N-glycan as an indicator of breast cancer recurrence with the current clinical biomarkers, i.e., CEA, CA 15-3 and CA125. |
| T10 | 1502-1668 | Sentence | denotes | The result revealed that, compared with CEA, CA 15-3 and CA125, the bifucosylation degree of N-glycans could be a more reliable indicator of breast cancer recurrence. |
| T1 | 0-98 | Sentence | denotes | Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer. |
| T2 | 99-167 | Sentence | denotes | Aberrant glycosylation is highly associated with cancer progression. |
| T3 | 168-409 | Sentence | denotes | The aim of this study was to compare bifucosylated N-glycans in sera obtained from healthy controls and breast cancer patients, with the goal of identifying a potential indicator for monitoring the recurrence and metastasis of breast cancer. |
| T4 | 410-549 | Sentence | denotes | A unique structural pattern of bifucosylated N-glycan, with both core and antennary fucosylation, was identified in breast cancer patients. |
| T5 | 550-689 | Sentence | denotes | The spectrum of antennary fucosylation was a composite of the standard spectra of Lewis X and H2, indicating a mixture of the two epitopes. |
| T6 | 690-999 | Sentence | denotes | Permethylated N-glycans of the glycoproteins extracted from 91 breast cancer patients and 43 healthy controls were detected using linear ion-trap quadrupole-electrospray ionization mass spectrometry, which appeared to be a highly sensitive and useful approach in the detection and identification of N-glycans. |
| T7 | 1000-1185 | Sentence | denotes | To evaluate MS profile data, several statistical tools were applied, including Student's t-test, partial least squares discriminant analysis and receiver-operating characteristic curve. |
| T8 | 1186-1337 | Sentence | denotes | The results showed that the measurement of bifucosylation degree and CEA levels had an improved diagnostic performance compared with that of CEA alone. |
| T9 | 1338-1501 | Sentence | denotes | We compared the potential of bifucosylated N-glycan as an indicator of breast cancer recurrence with the current clinical biomarkers, i.e., CEA, CA 15-3 and CA125. |
| T10 | 1502-1668 | Sentence | denotes | The result revealed that, compared with CEA, CA 15-3 and CA125, the bifucosylation degree of N-glycans could be a more reliable indicator of breast cancer recurrence. |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 18-23 | FMAID:167330 | denotes | serum |
| _T2 | 24-36 | FMAID:167256 | denotes | glycoprotein |
| _T3 | 24-36 | FMAID:62925 | denotes | glycoprotein |
| _T4 | 84-90 | FMAID:97486 | denotes | breast |
| _T5 | 84-90 | FMAID:9601 | denotes | breast |
| _T6 | 272-278 | FMAID:97486 | denotes | breast |
| _T7 | 272-278 | FMAID:9601 | denotes | breast |
| _T8 | 395-401 | FMAID:97486 | denotes | breast |
| _T9 | 395-401 | FMAID:9601 | denotes | breast |
| _T10 | 526-532 | FMAID:9601 | denotes | breast |
| _T11 | 526-532 | FMAID:97486 | denotes | breast |
| _T12 | 595-604 | FMAID:50603 | denotes | composite |
| _T13 | 595-604 | FMAID:146309 | denotes | composite |
| _T14 | 721-734 | FMAID:62925 | denotes | glycoproteins |
| _T15 | 721-734 | FMAID:167256 | denotes | glycoproteins |
| _T16 | 753-759 | FMAID:9601 | denotes | breast |
| _T17 | 753-759 | FMAID:97486 | denotes | breast |
| _T18 | 1091-1095 | FMAID:178661 | denotes | test |
| _T19 | 1409-1415 | FMAID:97486 | denotes | breast |
| _T20 | 1409-1415 | FMAID:9601 | denotes | breast |
| _T21 | 1643-1649 | FMAID:9601 | denotes | breast |
| _T22 | 1643-1649 | FMAID:97486 | denotes | breast |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 831-835 | http://www.uniprot.org/uniprot/Q9UFF0 | denotes | trap |
| T2 | 1012-1014 | http://www.uniprot.org/uniprot/Q99707 | denotes | MS |
| T3 | 1255-1258 | http://www.uniprot.org/uniprot/P06731 | denotes | CEA |
| T4 | 1327-1330 | http://www.uniprot.org/uniprot/P06731 | denotes | CEA |
| T5 | 1478-1481 | http://www.uniprot.org/uniprot/P06731 | denotes | CEA |
| T6 | 1542-1545 | http://www.uniprot.org/uniprot/P06731 | denotes | CEA |
| T7 | 1483-1490 | http://www.uniprot.org/uniprot/Q9BXA4 | denotes | CA 15-3 |
| T8 | 1547-1554 | http://www.uniprot.org/uniprot/Q9BXA4 | denotes | CA 15-3 |
| T9 | 1495-1500 | http://www.uniprot.org/uniprot/Q8WXI7 | denotes | CA125 |
| T10 | 1559-1564 | http://www.uniprot.org/uniprot/Q8WXI7 | denotes | CA125 |
uniprot-mouse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 831-835 | http://www.uniprot.org/uniprot/Q05117 | denotes | trap |
| T2 | 831-835 | http://www.uniprot.org/uniprot/Q8K1H1 | denotes | trap |
| T3 | 1012-1014 | http://www.uniprot.org/uniprot/A6H5Y3 | denotes | MS |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 91-97 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
| T2 | 99-107 | http://purl.bioontology.org/ontology/NCBITAXON/317910 | denotes | Aberrant |
| T3 | 148-154 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
| T4 | 279-285 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
| T5 | 402-408 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
| T6 | 484-493 | http://purl.bioontology.org/ontology/NCBITAXON/293542 | denotes | antennary |
| T7 | 533-539 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
| T8 | 566-575 | http://purl.bioontology.org/ontology/NCBITAXON/293542 | denotes | antennary |
| T9 | 760-766 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
| T10 | 1255-1258 | http://purl.bioontology.org/ontology/NCBITAXON/1107390 | denotes | CEA |
| T11 | 1327-1330 | http://purl.bioontology.org/ontology/NCBITAXON/1107390 | denotes | CEA |
| T12 | 1416-1422 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
| T13 | 1478-1481 | http://purl.bioontology.org/ontology/NCBITAXON/1107390 | denotes | CEA |
| T14 | 1542-1545 | http://purl.bioontology.org/ontology/NCBITAXON/1107390 | denotes | CEA |
| T15 | 1650-1656 | http://purl.bioontology.org/ontology/NCBITAXON/6754 | denotes | cancer |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 108-121 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
| T2 | 232-236 | http://purl.obolibrary.org/obo/GO_0004617 | denotes | sera |
| T3 | 494-506 | http://purl.obolibrary.org/obo/GO_0036065 | denotes | fucosylation |
| T4 | 576-588 | http://purl.obolibrary.org/obo/GO_0036065 | denotes | fucosylation |
| T5 | 920-929 | http://purl.obolibrary.org/obo/GO_0046960 | denotes | sensitive |
| T6 | 1255-1258 | http://purl.obolibrary.org/obo/GO_0033848 | denotes | CEA |
| T7 | 1327-1330 | http://purl.obolibrary.org/obo/GO_0033848 | denotes | CEA |
| T8 | 1478-1481 | http://purl.obolibrary.org/obo/GO_0033848 | denotes | CEA |
| T9 | 1542-1545 | http://purl.obolibrary.org/obo/GO_0033848 | denotes | CEA |
| T10 | 1483-1485 | http://purl.obolibrary.org/obo/GO_0033968 | denotes | CA |
| T11 | 1547-1549 | http://purl.obolibrary.org/obo/GO_0033968 | denotes | CA |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 475-479 | http://purl.obolibrary.org/obo/GO_0019013 | denotes | core |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-23 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
| T2 | 84-90 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| T3 | 272-278 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| T4 | 395-401 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| T5 | 526-532 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| T6 | 753-759 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| T7 | 1409-1415 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| T8 | 1643-1649 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
GlycoBiology-Motifs
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 219-228 | http://rdf.glycoinfo.org/glycan/G00027MO | denotes | N-glycans |
| T2 | 704-713 | http://rdf.glycoinfo.org/glycan/G00027MO | denotes | N-glycans |
| T3 | 989-998 | http://rdf.glycoinfo.org/glycan/G00027MO | denotes | N-glycans |
| T4 | 455-463 | http://rdf.glycoinfo.org/glycan/G00027MO | denotes | N-glycan |
| T5 | 1381-1389 | http://rdf.glycoinfo.org/glycan/G00027MO | denotes | N-glycan |
| T6 | 632-637 | http://rdf.glycoinfo.org/glycan/G00047MO | denotes | Lewis |
| T7 | 632-639 | http://rdf.glycoinfo.org/glycan/G00051MO | denotes | Lewis X |
Lectin
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| Lectin_T1 | 1483-1485 | https://acgg.asia/db/lfdb/LfDB0227 | denotes | CA |
| Lectin_T2 | 1547-1549 | https://acgg.asia/db/lfdb/LfDB0227 | denotes | CA |
GlycoBiology-Epitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-GlycoEpitope-B_T1 | 632-639 | http://www.glycoepitope.jp/epitopes/EP0011 | denotes | Lewis X |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 84-90 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T2 | 272-278 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T3 | 395-401 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T4 | 526-532 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T5 | 753-759 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T6 | 1409-1415 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T7 | 1643-1649 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
| PD-UBERON-AE-B_T8 | 18-23 | http://purl.obolibrary.org/obo/UBERON_0001977 | denotes | serum |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 84-97 | Disease | denotes | breast cancer | http://purl.obolibrary.org/obo/MONDO_0007254 |
| T2 | 148-154 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T3 | 272-285 | Disease | denotes | breast cancer | http://purl.obolibrary.org/obo/MONDO_0007254 |
| T4 | 395-408 | Disease | denotes | breast cancer | http://purl.obolibrary.org/obo/MONDO_0007254 |
| T5 | 526-539 | Disease | denotes | breast cancer | http://purl.obolibrary.org/obo/MONDO_0007254 |
| T6 | 753-766 | Disease | denotes | breast cancer | http://purl.obolibrary.org/obo/MONDO_0007254 |
| T7 | 1409-1422 | Disease | denotes | breast cancer | http://purl.obolibrary.org/obo/MONDO_0007254 |
| T8 | 1643-1656 | Disease | denotes | breast cancer | http://purl.obolibrary.org/obo/MONDO_0007254 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 84-97 | Phenotype | denotes | breast cancer | HP:0003002 |
| T2 | 148-154 | Phenotype | denotes | cancer | HP:0002664 |
| T3 | 272-285 | Phenotype | denotes | breast cancer | HP:0003002 |
| T4 | 395-408 | Phenotype | denotes | breast cancer | HP:0003002 |
| T5 | 526-539 | Phenotype | denotes | breast cancer | HP:0003002 |
| T6 | 753-766 | Phenotype | denotes | breast cancer | HP:0003002 |
| T7 | 913-929 | Phenotype | denotes | highly sensitive | HP:0041092 |
| T8 | 1409-1422 | Phenotype | denotes | breast cancer | HP:0003002 |
| T9 | 1643-1656 | Phenotype | denotes | breast cancer | HP:0003002 |
Glycosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 632-639 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Lewis X | http://www.glycoepitope.jp/epitopes/EP0011 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 84-90 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T2 | 272-278 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T3 | 395-401 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T4 | 526-532 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T5 | 753-759 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T6 | 1409-1415 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T7 | 1643-1649 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |